Literature DB >> 27867631

Optimizing the lung cancer screening interval: the world is waiting.

Carole A Ridge1, Phillip M Boiselle2.   

Abstract

Entities:  

Year:  2016        PMID: 27867631      PMCID: PMC5107488          DOI: 10.21037/jtd.2016.10.25

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  5 in total

Review 1.  Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening.

Authors:  Marjolein A Heuvelmans; Rozemarijn Vliegenthart; Matthijs Oudkerk
Journal:  J Thorac Imaging       Date:  2015-03       Impact factor: 3.000

2.  Lung cancer CT screening: is annual screening necessary?

Authors:  John K Field; Stephen W Duffy
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316

3.  Results of the two incidence screenings in the National Lung Screening Trial.

Authors:  Denise R Aberle; Sarah DeMello; Christine D Berg; William C Black; Brenda Brewer; Timothy R Church; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; Constantine A Gatsonis; David S Gierada; Amanda Jain; Gordon C Jones; Irene Mahon; Pamela M Marcus; Joshua M Rathmell; JoRean Sicks
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 4.  Lung Cancer Screening Update.

Authors:  Kathleen L Ruchalski; Kathleen Brown
Journal:  J Thorac Imaging       Date:  2016-07       Impact factor: 3.000

5.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Authors:  Edward F Patz; Erin Greco; Constantine Gatsonis; Paul Pinsky; Barnett S Kramer; Denise R Aberle
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316

  5 in total
  1 in total

1.  Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result.

Authors:  Hilary A Robbins; Christine D Berg; Li C Cheung; Anil K Chaturvedi; Hormuzd A Katki
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.